July 3, 2024
IPSEN – Buy-back programme – Art 5 of MAR – Week 26 – 2024
Aggregated presentation by day and by market Purchases of own shares from June 24th to 28th 2024 Name of the IssuerIdentity…
Pharmaceuticals, Biotechnology and Life Sciences
Aggregated presentation by day and by market Purchases of own shares from June 24th to 28th 2024 Name of the IssuerIdentity…
On June 21, we finalized the acquisition of Globion’s minority shares, bringing our stake to 100%. As planned, this transaction…
Venlo, The Netherlands, July 02, 2024 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to…
CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™),…
Data demonstrates that NKT cells are activated in airways in IPF patients and inhibition of type 1 invariant NKT (iNKT)…
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) — LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”),…
SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis…
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its…
China is the Third Country to Launch LEQEMBI Following the United States and JapanTOKYO and CAMBRIDGE, Mass., June 27, 2024…